You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant Glioma

Showing 26 - 50 of 4,916
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioma, Brain Tumor, Primary Brain Tumor Trial in Miami (3T MRI Scanner)

Recruiting
  • Glioma
  • +4 more
  • 3T MRI Scanner
  • Miami, Florida
    University of Miami
Mar 15, 2022

Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three

Recruiting
  • Malignant Glioma
  • D2C7-IT (6920 ng/mL via convection-enhanced delivery)
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 22, 2022

Malignant Brain Tumor, Malignant Glioma, Embryonal Tumor Trial in Paris, Villejuif (SonoCloud® (9 transducers))

Not yet recruiting
  • Malignant Brain Tumor
  • +2 more
  • SonoCloud® (9 transducers)
  • Paris, France
  • +2 more
Sep 26, 2022

High Grade Glioma Trial in Toronto (Supramarginal resection, Conventional (i.e. GTR) resection)

Recruiting
  • High Grade Glioma
  • Supramarginal resection
  • Conventional (i.e. GTR) resection
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
May 5, 2022

Glioma Trial in Spain, United States (LY2157299, Lomustine)

Active, not recruiting
  • Glioma
  • Baltimore, Maryland
  • +3 more
Oct 18, 2022

Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

Not yet recruiting
  • Diffuse Glioma
  • Malignant Glioma
  • Biospecimen Collection
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 6, 2023

Glioblastoma Trial in Cincinnati (Modified Atkins Ketogenic Diet)

Active, not recruiting
  • Glioblastoma
  • Modified Atkins Ketogenic Diet
  • Cincinnati, Ohio
    UC Health
Nov 15, 2021

Malignant Glioma Trial in Paris (Surgery, radiotherapy)

Completed
  • Malignant Glioma
  • Surgery
  • radiotherapy
  • Paris, France
    Florence Laigle
Nov 26, 2021

5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for

Not yet recruiting
  • High Grade Glioma
  • +10 more
  • 5-Aminolevulinic Acid (5-ALA) Gliolan®
  • Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
  • Guayaquil, Guayas, Ecuador
    Sociedad de Lucha Contra el Cáncer
Apr 28, 2023

Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

Recruiting
  • Brain Gliomas
  • Allogenic B7H3 CAR-γδT cell
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023

Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Stereotactic Radiosurgery
  • Lake Success, New York
    Northwell Health Brain Tumor Center
Feb 3, 2022

Glioma, Malignant Trial in Rom, Rome (histopathological analysis; morphological and non-morphological magnetic resonance)

Completed
  • Glioma, Malignant
  • histopathological analysis; morphological and non-morphological magnetic resonance
  • Rom, Roma, Italy
  • +1 more
Mar 28, 2023

Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

Not yet recruiting
  • Neoplasms
  • +7 more
  • Biological G207
  • Birmingham, Alabama
    Children's of Alabama
Jun 1, 2022

Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

Completed
  • Diffuse Intrinsic Pontine Glioma
  • +6 more
  • Washington, District of Columbia
  • +6 more
Jan 12, 2023

2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery

Recruiting
  • Glioma
  • +4 more
  • intraoperative ultrasound
  • Valladolid, Spain
    University Hospital Rio Hortega
May 16, 2023

Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

Recruiting
  • Malignant Glioma
  • High Grade Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +4 more
  • Birmingham, Alabama
  • +2 more
Feb 2, 2023

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Malignant Glioma Trial in Nashville (Bevacizumab, Temozolomide, Vitamin C)

Completed
  • Malignant Glioma
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Mar 9, 2022

Malignant Glioma, Recurrent Glioma Trial in Beijing (personalized vaccine)

Recruiting
  • Malignant Glioma
  • Recurrent Glioma
  • personalized vaccine
  • Beijing, Beijing, China
    Xuanwu Hospital, Capital Medical University
Jun 26, 2021

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

AI R&D Tool in Adult Glioma and Other Primary Brain Tumours

Not yet recruiting
  • Brain Tumor
  • +4 more
  • Resection
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Sep 15, 2023

Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

Active, not recruiting
  • Malignant Glioma
  • +2 more
  • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
  • Concurrent Optune and RT followed by Optune System alone
  • Los Angeles, California
  • +8 more
Jan 17, 2023

Malignant Glioma, Glioblastoma Multiforme Trial in Ann Arbor (Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L)

Completed
  • Malignant Glioma
  • Glioblastoma Multiforme
  • Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L
  • Ann Arbor, Michigan
    University of Michigan Health System Department of Neurosurgery
Aug 25, 2021